FIELD: pharmaceutics.
SUBSTANCE: disclosed is a medical container containing a liquid pharmaceutical composition containing a compound represented by chemical formula 1, or a pharmaceutically acceptable salt thereof, where the medical container includes a plastic container; glass container, the inner side of which is coated with silicone oil, SiO2 or SiOCH; or a de-alkali glass container. Said liquid pharmaceutical composition additionally contains cyclodextrin and an isotonic agent, which is D-mannitol or NaCl, and said liquid pharmaceutical composition has pH from 4.0 to 6.0.
EFFECT: invention provides stable storage of a liquid pharmaceutical composition containing a compound of chemical formula 1 or a pharmaceutically acceptable salt thereof.
2 cl, 5 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL COMPOSITION FOR INJECTIONS CONTAINING 1-(5-(2,4-DIFLUOROPHENYL)-1-((3-FLUOROPHENYL)SULPHONYL)-4-METHOXY-1H-PYRROL-3-YL)-N-METHYLMETHANAMINE | 2022 |
|
RU2829138C2 |
| STABILISED PHARMACEUTICAL DOCETAXEL-CONTAINING COMPOSITION | 2009 |
|
RU2478370C2 |
| COMPOSITION FOR PARENTERAL ADMINISTRATION CONTAINING SIPONIMOD | 2018 |
|
RU2803937C2 |
| AQUEOUS COMPOSITION CONTAINING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDINE-1-YL]CARBONYL} PHENYL)-3-[4-(4,6- DIMORPHOLINE-4-YL-1,3,5-TRIAZINE-2-YL)PHENYL]UREA | 2019 |
|
RU2772287C1 |
| STABLE INJECTABLE PARACETAMOL FORMULATION FOR INJECTIONS | 2011 |
|
RU2519764C1 |
| GLYCOPEPTIDE ANTIBIOTIC SALT AND PHARMACEUTICAL COMPOSITIONS BASED THEREON | 2023 |
|
RU2827992C1 |
| HYDROCHLORIDE SALT OF 5-[3-(3-HYDROXYPHENOXY)AZETIDIN-1-YL]-5-METHYL-2,2-DIPHENYLHEXANAMIDE | 2008 |
|
RU2422439C2 |
| STABILIZED PEMETREXED COMPOSITION | 2013 |
|
RU2620341C2 |
| COMPLEX GRANULATED COMPOSITION WITH IMPROVED STABILITY, INCLUDING LEVOCETRIZINE AND MONTELEUKAST | 2014 |
|
RU2671491C2 |
| COMPOSITIONS BASED ON PARTIALLY FLUORINATED ALKANES, CONTAINING ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | 2019 |
|
RU2808451C2 |
